About
Technology
Issues
FAQ
Links
Official Page
Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.